5th International
Bone Marrow Failure
Bone Marrow Failure:
A condition that occurs when the bone marrow stops making enough healthy blood cells. The most common of these rare diseases are aplastic anemia, myelodysplastic syndromes (MDS) and paroxysmal nocturnal hemoglobinuria (PNH). Bone marrow failure can be acquired (begin any time in life) or can be…
Disease
Scientific Symposium 2016
March 17-18, 2016
Hilton Rockville Hotel, Rockville, Maryland
An Intensive Two-Day Conference Convening International Experts at the Forefront of Research and Treatment of Bone Marrow Failure Disease
You
are cordially invited to attend the International Bone Marrow Failure
Disease Scientific Symposium 2016. This symposium will bring together
physicians treating these diseases and laboratory researchers studying
the immunology and cell biology of bone marrow failure disease to:
- Discuss current areas of controversy
- Share recent research results
- Propose specific recommendations for the highest priority directions for basic and clinical research clinical research: A type of research that involves individual persons or a group of people. There are three types of clinical research. Patient-oriented research includes clinical trials which test how a drug, medical device, or treatment approach works in people. Epidemiology or behavioral studies look at the… needed to advance the field of research
Once
thought of as distinct,
aplastic anemia
aplastic anemia:
(ay-PLASS-tik uh-NEE_mee-uh) A rare and serious condition in which the bone marrow fails to make enough blood cells - red blood cells, white blood cells, and platelets. The term aplastic is a Greek word meaning not to form. Anemia is a condition that happens when red blood cell count is low. Most…
,
myelodysplastic syndromes
myelodysplastic syndromes:
(my-eh-lo-diss-PLASS-tik SIN-dromez) A group of disorders where the bone marrow does not work well, and the bone marrow cells fail to make enough healthy blood cells. Myelo refers to the bone marrow. Dysplastic means abnormal growth or development. People with MDS have low blood cell count for at…
(MDS), and
paroxysmal nocturnal hemoglobinuria
paroxysmal nocturnal hemoglobinuria:
(par-uk-SIZ-muhl nok-TURN-uhl hee-muh-gloe-buh-NYOOR-ee-uh) A rare and serious blood disease that causes red blood cells to break apart. Paroxysmal means sudden and irregular. Nocturnal means at night. Hemoglobinuria means hemoglobin in the urine. Hemoglobin is the red part of red blood cells. A…
(PNH) are now believed to
be linked by similar pathophysiologic pathways.
With
exciting new developments in the treatment of these diseases and new
insights into the molecular pathogenesis of the diseases, AA&MDSIF
is coordinating this symposium to explore opportunities for
collaborative research.
The
symposium program has been designed to address the most up-to-date
issues in each topic area and to encourage participant interaction.
Each session includes presentations
by experts in the field followed by open discussion.
by experts in the field followed by open discussion.
Poster session and networking opportunities are included in the program.
Limited travel support is available for new investigators. For more information, contact Alice Houk at (301) 279-7202 x101.
Limited travel support is available for new investigators. For more information, contact Alice Houk at (301) 279-7202 x101.